ESR1 and cancer: Restraining type I IFNs and type I ISGs from expression has been considered as a common mechanism for cancer cells to escape from immune surveillance.[43] We therefore propose that suppression of these genes by KDM5C might, at least partially, account for its oncogenic role in ERα‐positive breast cancers.